Reading this on a mobile device? Try our optimized mobile version here:

April 6, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Lixisenatide shows efficacy in type 2 diabetes management
    A higher proportion of drug-naive type 2 diabetes patients achieved blood glucose levels lower than 7% with once-daily lixisenatide for 12 weeks compared with those who received placebo treatment, researchers reported in Diabetes Care. Lixisenatide-treated patients also had bigger drops in two-hour postprandial glucose levels than those in the placebo group, researchers noted. Medscape (free registration)/Reuters (4/2) LinkedInFacebookTwitterEmail this Story
  • Diabetes plus MI raises in-hospital mortality in patients
    A study presented at the annual meeting of the American College of Cardiology revealed diabetes patients hospitalized for myocardial infarction were more likely to experience in-hospital stroke, recurrent MI, and heart failure or pulmonary edema than MI patients who did not have diabetes. Researchers also found diabetes patients with MI face an 18% higher risk of in-hospital mortality than those without diabetes. Family Practice News (4/5) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • Review: Brain signals affect appetite control in obese
    A review of research shows overweight and obese individuals appear to have stronger brain signals to eat when presented with sweet or fatty foods and that learned behaviors and motivational signals may affect brain regions associated with appetite control. "The emerging imaging literature supports the view that although there is not a single pathway leading to obesity, it is a neurobehavioral problem: a disease that results from a vulnerable brain in an unhealthy environment," researcher Alain Dagher wrote in Trends in Endocrinology and Metabolism. (4/5) LinkedInFacebookTwitterEmail this Story
  • Parenting practices impact soda consumption in children
    Children from higher-income families in Belgium had a 42% lower soda intake than their lower-income counterparts, according to a study in Appetite. Researchers said not offering soda at mealtimes, restricting children from drinking soda whenever they want and not having soda in the house explain the disparity in soda consumption between the income groups. (4/5) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • HIT policy group examines stage 2 MU measures
    Some members of the HIT Policy Committee at a meeting Wednesday showed concerns that the proposed stage 2 meaningful use regulations would compel qualified providers to gather data for 120 suggested new measures to update their certified EHR systems, when some of those measures may likely never be tracked by the federal government. The panel's quality measures workgroup believes the proposal did not adequately address care coordination, says workgroup chairman David Lansky. "We’re not going to be able to see a lot of measured improvement around care coordination if this is the best we’re able to do over the next three years," Lansky added. Healthcare IT News (4/5), Government Health IT online (4/4) LinkedInFacebookTwitterEmail this Story
  • Hospitals can reap benefits from clinical documentation improvement
    The ICD-10 transition is driving hospitals to boost clinical documentation. But regardless of what the CMS decides on the compliance deadline, experts say hospitals can use clinical documentation improvement to meet quality measures, enhance care delivery and manage revenue, which is key to seeing a demonstrable return on investment now and after implementing ICD-10, writes Carl Natale. (4/3) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • Experts create stem cell line that may aid in diabetes research
    Researchers at the Children's Hospital of Philadelphia's Center for Cellular and Molecular Therapeutics created a line of human stem cells that may help generate insulin-producing beta cells. The new stem cell line may also serve as a modeling tool to examine how human diseases progress, researchers reported in Cell/Stem Cell. (4/5) LinkedInFacebookTwitterEmail this Story
Faced with the choice between changing one's mind and proving that there is no need to do so, almost everyone gets busy on the proof."
--John Kenneth Galbraith,
Canadian-American economist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Aaron Kern (202) 407-7866
A powerful website for SmartBrief readers including:
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information